Contractual Procurement Alternatives of Air Force Contingency Pharmaceuticals: A Cost-Benefit Analysis
Purpose — This paper aims to explore effective supply chain principles, through the theory of transaction cost economics, as measures to improve current contingency pharmaceutical item shortfalls in the Air Force Medical Service (AFMS) Contingency Pharmaceutical Programme. Design/methodology/approach — In this research, AFMS contingency pharmaceutical data was collected from various databases, including the Joint Medical Asset Repository, Medical Contingency Requirements Workflow and the Medical Requirements List. Through the methodology of cost-benefit analysis, alternative sourcing and fulfilment practices are evaluated. Findings — The findings of this research indicate that the application of centralized purchasing principles, in an effort to leverage prime vendor contract fill rates for shortage items, can lead to 12%–17% increases in pharmaceutical material availability across the programme. Originality/value — This research clearly shows that consolidating demand for shortage items across Active Duty War Reserve Material assemblages, though applications of centralized purchasing principles that leverage prime vendor contract fill rates, can lead to substantial increases in material availability at costs that justify the calculated benefits.
Journal of Defense Analytics and Logistics
Brubakken, A. J., Dickens, J. M., Anderson, J., & Cunningham, W. (2020). Contractual procurement alternatives of Air Force contingency pharmaceuticals: a cost-benefit analysis. Journal of Defense Analytics and Logistics, 4(2), 111–128. https://doi.org/10.1108/JDAL-04-2020-0007
All articles published in JDAL are published Open Access under a Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. CC BY 4.0
Sourced from the publisher version of record at Emerald. The citation and DOI link are noted below.